China: Biotech companies, experts highlight threats of U.S. act to innovation, cooperation
The U.S. Biosecure Act, approved by the House of Representatives on Tuesday, has drawn harsh criticism from concerned Chinese companies, global pharmaceutical firms and industry insiders. Targeting the so-called “China…
